Table 5.
Statistical analyses of prediction from Wang et al. and from the SILCS LGFE scoring for the p38 MAP kinase inhibitors reported by Goldstein et al.
| Wang et al. | SILCS LGFEave | SILCS LGFEmin | |
|---|---|---|---|
| R2 | 0.43 | 0.39 | 0.40 |
| PI | 0.66 | 0.67 | 0.68 |
| RMSD | 1.42 | 2.19 | 2.31 |
| AAD | 1.09 | 1.85 | 1.74 |
| #Correct/33 | 20 | 25 | 25 |
Note: 34 compounds included in data set, with relative energies offset to compound 2a such that 33 compounds included in the analysis of # correct.